NCT04063124: A trial that was reported late by The University of Texas Health Science Center at San Antonio
This trial has reported, although it was 55 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04063124 |
|---|---|
| Title | Pilot Study to Investigate the Safety and Feasibility of Senolytic Therapy to Modulate Progression of Alzheimer's Disease (SToMP-AD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 14, 2020 |
| Completion date | Dec. 10, 2021 |
| Required reporting date | Dec. 10, 2022, midnight |
| Actual reporting date | Feb. 3, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 55 |